Home

Garry Arthur Neil, CEO and Chairman: Avalo Therapeutics AVTX Buy · Filed 23/06/13

Trade details

Type
Insider buy
Amount
$13,680
Shares · price
4,000 sh · $3.42 a share
Held after
13,220 sh
Trade date
23/06/09
Filed
23/06/13
Days to filing
4 days

3 insiders bought this week

Insiders buying this week
3 insiders
Holding change
+43.4%

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/10~23/07/09

Garry Arthur Neil's recent trades

No other trades yet.